<DOC>
	<DOC>NCT00395603</DOC>
	<brief_summary>To compare the effectiveness of ezetimibe/simvastatin 10/40 daily to atorvastatin 80 daily in reducing the concentration of ldl-c at endpoint after 6 weeks of treatment.</brief_summary>
	<brief_title>Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Greater than 18 years of age Treated for at least the last 3 months with a daily dose of atorvastatin 40 mg Existing coronary heart disease and cholesterol &gt; 4.0 mmol/l Uncontrolled diabetes Elevated liver function tests Elevated creatine kinase (ck) Triglycerides (tg) &gt; 4.5 mmol/l Drug or alcohol dependency within 6 months prior to visit 1 Woman receiving hormonal therapy who have not been maintained on a stable dose and regimen for at least 8 weeks and are willing to continue the same regimen for the duration of the study Woman of childbearing potential not using an acceptable method of birth control Women who are pregnant or breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>